Improving drug discovery through patient cell-screening.
ArcoScreen SA
Incorporated
12.07.2021Headquarters
LausanneSupport
ArcoScreen SA is an EPFL spin off founded in July 2021 in Lausanne. We are specialized in the development of tools for G protein coupled receptors (GPCRs) drug discovery. Our revolutionary technology enables the prediction of a drugs efficacy rapidly and early in the drug discovery process (lead optimization and mode of action identification) before expensive clinical trials directly on primary cells.
Our mission is to revolutionize drug discovery to improve patients lives.
News
The most promising Swiss biotech startups and scale-ups of 2024, according to investors (TOP 100)
First National Flagship Event 2023: Credit Suisse Investors and TOP 100 Startups connect over archery in Lausanne (venturelab.swiss)
MassChallenge Switzerland 2023 Cohort is here ! (startupticker.ch)
The 18 most promising biotech startups, according to investors (TOP 100)
ArcoScreen and DAAV get FIT boost (startupticker.ch)
Venture Leaders Medtech 2022: Captain’s blog by Oncobit CEO Claudia Scheckel (venturelab.swiss)
Venture Leaders Medtech: 10 Swiss medtech startups showcase cutting-edge innovations in Boston (venturelab.swiss)
ArcoScreen: The Venture Leader Medtech facilitating accurate, cheaper, and faster drug discoveries (venturelab.swiss)
Swiss entrepreneurs secure a spot in the Forbes 30 Under 30 Europe list (startupticker.ch)
The road to Boston: The Venture Leaders Medtech 2022 kick-off their international roadshow (venturelab.swiss)
Venture Leaders Medtech 2022: 10 innovative startups will advance their global growth in Boston (startupticker.ch)
Venture Leaders Medtech 2022: 10 innovative startups will advance their global growth in Boston (venturelab.swiss)
IMD 37 Startup Competition 2022 Winners announced (startupticker.ch)
Margaux Duchamp wins Lopez-Loreta Foundation Prize 2021 (startupticker.ch)
ArcoScreen awarded CHF 1Mio Lopez-Loreta Prize to enable the team expansion and product development (venturekick.ch)
ArcoScreen wins CHF 150,000 to revolutionize drug discovery (startupticker.ch)
ArcoScreen wins CHF 150,000 to revolutionize drug discovery (venturekick.ch)
Two Venture Kick alumni win the Isabelle Musy Award for outstanding female entrepreneurs (venturekick.ch)
The Startup Champions Seed Night 2020 showcased 18 promising startups in a hybrid event (venturelab.swiss)
Milestones news
ArcoScreen joins the INNOSUISSE CORE COACHING program
Videos and Presentations
Deux chercheuses de l'EPFL ambitionnent de diminuer le taux d'échec lors du développement des médicaments contre Alzeihmer et Parkinson. Explication.
ArcoScreen: Screening patient cells improve drug discovery
Pitch Startup Champions Seed Night 2020